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Objective: MicroRNAs were identified as master-switch molecules limiting acute inflam
matory response. This study investigated the potential role of microRNA (miR)-223 in the
mechanism of gout.
Methods: Wild-type (WT) and miR-223 knock-out (KO) mice were used to evaluate the
phenotypes of gout models. Inflammatory cytokines were measured in air pouch and
peritoneal cavity lavage fluid. In addition to miR-223 level in gout patients, miR-223 and
pro-inflammatory genes were examined in bone marrow-derived macrophages (BMDMs)
from mice as well as peripheral blood mononuclear cells from healthy controls (HC) treated
with monosodium urate (MSU) crystals in vitro.
Results: MiR-223 was up-regulated in the early phase in BMDMs from WT mice after MSU
challenge and decreased rapidly, and this was not observed in miR-223 KO mice in vitro. In
addition, miR-223 was required for macrophages homeostasis. In comparison with WT mice
in vivo, miR-223 deficiency exacerbated swelling index of MSU-induced inflammation in
foot pad and ankle joint models. MiR-223 deficiency also markedly aggravated inflammatory
cells infiltration and cytokines release including interleukin (IL)-1β, IL-6 and monocyte
chemotactic protein-1 (MCP-1) in the air pouch and peritonitis models. In the in vitro
experiments, miR-223 deficiency promoted the inflammatory response by targeting NLR
family pyrin domain containing protein 3 (NLRP3). Besides, miR-223 level was downregulated in gout patients and in HC exposed to MSU in vitro.
Conclusion: MiR-223 was down-regulated in gout patients and miR-223 deficiency
exacerbated inflammatory response in diverse murine models, suggesting that upregulation of miR-223 could be a potential therapeutic strategy for alleviating gouty
inflammation.
Keywords: miR-223, gout, animal models, cytokines, monosodium urate

Introduction
Gout is an auto-inflammatory disease caused by the accumulation of monoso
dium urate (MSU) crystals in joints and connective tissues causing an intense
inflammatory response and joint dysfunction. Recurrent attacks and spontaneous
remission are typical clinical characteristics of acute gouty arthritis, which are
important in the differential diagnosis of gouty arthritis from other types of
arthritis. Currently, an acute gout attack is mediated by interleukin (IL)-1β,
which is central to the initiation of acute arthritis and is produced due to
activation of Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB and NLR
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family pyrin domain containing protein 3 (NLRP3)
inflammasome signaling pathways by MSU crystals.1–6
However, the key regulatory mechanisms related to
gouty inflammation have yet to be clarified.
MicroRNAs are a class of small, endogenous non-coding
RNAs of approximately 20 nucleotides (nt) in length that
regulate gene expression post-transcriptionally by binding to
3ʹ-untranslated regions (UTRs), coding sequences or 5ʹUTRs of target messenger RNAs (mRNAs) and lead to
inhibition of translation or mRNA degradation.7,8
MicroRNAs control the expression of genes involved in
several biological processes such as apoptosis, proliferation,
differentiation and metastasis.7,8 In addition, several
microRNAs have been identified to be negative regulators
of inflammation.9,10 One recent study has shown that
microRNA-223 (miR-223) acts as a negative regulator of
NLRP3 inflammasome activity in vitro.11 Given that miR223 is a negative regulator of NLRP3, and that NLRP3 is
important for MSU-induced inflammation,12,13 we hypothe
sized that the loss of miR-223 may exacerbate the inflamma
tory response to MSU crystals.
In this study, miR-223 level was analyzed in gout
patients and diverse phenotypes of MSU-induced gout
murine models, including ankle arthritis, foot pad arthritis,
subcutaneous air pouch and peritoneal cavity models, were
evaluated in miR-223 knockout (KO) and wild-type (WT)
mice in vivo. In addition, the targeting gene of miR-223
for regulating gouty inflammation was confirmed in bone
marrow-derived macrophages (BMDMs) in vitro.

Materials and Methods
Patients
A total of 243 male patients with primary gout visited the
Department of Rheumatology of the Affiliated Hospital of
North Sichuan Medical College, China. These patients were
confirmed to have primary gout according to the American
College of Rheumatology classification criteria (1977)14 and
were divided into acute gout (AG, 140 cases) and intercritical
gout (IG, 103 cases) according to their clinical manifestations
and C-reactive protein or erythrocyte sedimentation rate.
Patients with gout had no history of cancer, hematopathy,
nephropathy, infection or other autoimmune diseases, and did
not receive any systemic anti-inflammatory treatments or
medications to control the production and elimination of
uric acid before the blood samples were obtained. Medical
history and clinical data were obtained from all patients
(Table 1). One hundred age-matched males who underwent
regular physical examination during the same periods were
enrolled as healthy controls (HC). They have no personal or
familial history of gout and any systemic inflammatory dis
eases. In addition, routine blood counts and laboratory bio
chemical examinations of conventional parameters were
normal. All participants in this study were from the
Chinese Han population. The study was approved by the
institutional research ethics committee of Affiliated
Hospital of North Sichuan Medical College and written
informed consent was obtained from each subject.
Experiments using human blood were performed in accor
dance with the Declaration of Helsinki (No:2021ER(A)033).

Table 1 Comparison of Laboratory Indexes in Patients with Acute Gout, Intercritical Gout and Healthy Controls
Laboratory Indexes

AG Group (n=140)

IG Group (n=103)

HC Group (n=100)

F/t value

p value

WBC(×109/L)

8.9±3.2

GR(×109/L)

6.1±2.9

7.0±2.5

5.9±1.4

18.1

<0.001

4.6±2.1

3.3±1.0

21.4

ESR(mm/h)
UA(μmol/L)

<0.001

22.4±13.5
475.7±110.4

14.2±7.4
469.4±77.4

–
323.2±47.4

1.8
36.6

0.188
<0.001

GLOB(g/L)

31.9±5.2

31.3±5.0

28.3±3.3

10.1

<0.001

TG(mmol/L)
HDLC(mmol/L)

2.5±1.4
1.0±0.2

2.1±0.8
1.0±0.2

1.3±0.6
1.4±0.4

17.7
15.7

<0.001
<0.001

TC(mmol/L)

5.0±1.1

5.1±0.7

4.7±0.7

2.4

0.096

LDLC(mmol/L)
VLDL(mmol/L)

2.7±0.7
1.3±0.8

2.7±0.6
1.2±0.6

2.5±0.7
0.7±0.3

0.8
15.5

0.472
<0.001

apoA1(g/L)

1.03±0.24

1.2±0.21

1.31±0.20

11.4

<0.001

apoB100(g/L)
GLU(mmol/L)

0.85±0.19
6.0±1.5

0.90±0.25
5.8±1.2

0.71±0.21
5.1±0.5

3.6
11.4

0.042
<0.001

ALB(g/L)

43.9±3.5

45.2±2.6

44.6±2.0

4.3

0.017

Abbreviations: AG, acute gout; IG, intercritical gout; HC, healthy controls; WBC, white blood cell; GR, granulocyte; ESR, erythrocyte sedimentation rate; UA, uric acid;
GLOB, Globulin; TG, total triglycerides; TC, total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density lipoprotein cholesterol; VLDL, very lowdensity lipoprotein; apoA1, Apolipoprotein A1; apoB100, Apolipoprotein B100; GLU, glucose; ALB, albumin.
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Animals
MiR-223 KO mice were produced refer to the described
method15 and kindly provided by the CBR Institute for
Biomedical Research, Harvard Medical School, Boston,
USA. WT C57BL/6 mice were purchased from the
Jackson Laboratory, Bar Harbor, USA. All mice used in
these experiments were 8–10 weeks old. All handling of
the mice and experimental procedures were developed in
accordance with the requirements of the Institutional Animal
Care and Use Committee of Henry Ford Health System
(Detroit, USA) and also were approved by the Committee.

MSU Crystals Formation
MSU crystals were prepared as described previously.16
Briefly, 1.0 g uric acid (Sigma-Aldrich, USA) was dis
solved in 200 mL sterile water containing 6.0 mL of 1
M NaOH. The pH was adjusted to 7.2 and the solution was
sterilized by heating at 180°C for 2 h. The precipitate was
filtered from the solution, dried under low heat and sus
pended in phosphate-buffered saline (PBS) at
a concentration of 50 mg/mL. All reagents were prepared
under pyrogen-free conditions.

Yang et al

BMDMs treated with MSU for 2 or 4 h was measured by
a FACSAria II (BD Biosciences, USA).

Gout Model
Mice were placed under anesthesia [150:10 mg/kg keta
mine:xylazine injected intraperitoneally] and were injected
with the MSU crystal suspension into the right foot pad
(1 mg suspended in 40 μL PBS) or ankle joint (0.5 mg
suspended in 20 μL PBS).18 Inflammation parameters were
evaluated with an electronic caliper post-MSU crystal
injection at different time points (6, 24 and 48 h).
An injection of 5 mL sterile air into the subcutaneous
tissue on the back of each mouse was carried out to form
an air pouch. On day 7, the MSU crystal suspension
(3 mg) was injected into the air pouch.19 In the MSUinduced peritonitis model, MSU crystals (3 mg) were
injected into the peritoneal cavity.20 The total number of
cells in air pouch lavage fluid (APLF) and peritoneal
cavity lavage fluid (PCLF) containing 2 mL PBS were
harvested at different time points and counted using
a hematocytometer.

Flow Cytometry Analysis
BMDMs Culture and MSU Stimulation
BMDMs were cultured in RPMI-1640 (Gibco, Life
Technologies, USA) supplemented with 10% fetal bovine
serum (FBS), penicillin (100 units/mL), streptomycin
(100 μg/mL) and 30 ng/mL macrophage colony-stimulating
factor (#0914245, Peprotech, USA). After 7 days, the cells
were harvested with 0.25% trypsin. The phenotypic validation
of BMDMs (Figure 1B) was measured by flow cytometry and
staining with FITC-conjugated anti-CD11b and PE-conjugated
anti-F4/80 antibodies (both diluted 1:200). The BMDMs were
double-positive for CD11b and F4/80. The BMDMs were
harvested at 30 or 60 minutes after MSU crystal challenge
for MSU phagocytosis of macrophages. Phagocytosis of MSU
crystals was analyzed by the side scatter (SSC) change in flow
cytometry.
The harvested BMDMs were divided into 2×106 cells/
well in a 6 well/plate containing 1 mL RPMI-1640+10%
FBS. According to the experimental protocol for the in vitro
experiment,17 the BMDMs were primed with 50ng/mL lipo
polysaccharide (LPS) for 4 hours before the BMDMs were
stimulated with MSU crystals suspension (MSU 100 μg/mL
final concentration) for 4 or 8 h. The cells were harvested for
measurement of miRNA, mRNA or protein. In addition,
intracellular tumor necrosis factor (TNF)-α production in

Journal of Inflammation Research 2021:14

The BMDMs (2×106) treated with MSU for 2 or 4 h were
harvested and stained with monoclonal antibody (mAb)
F4/80-PE or CD11b-FITC for 30 min at 4°C. The cells
were then fixed by intracellular fixation buffer for 30 min
at 4°C. After rinsing twice with permeabilization buffer,
the cells were dyed with mAb TNF-α-PE-Cy7 for 30 min
at 4°C.
APLF or PCLF cells (2×106) were incubated with Fc
block (clone 2.4G2) for 15 min and then stained with mAb
Ly-6G-PE, F4/80-APC, and CD11b-FITC for 30 min at 4°
C. The cells were suspended in running buffer (PBS con
taining 0.5% FBS and 2 mM EDTA), and then sorted and
analyzed on a FACSAria II (BD Biosciences). All antibo
dies were purchased from eBioscience (USA). Data were
acquired using CellQuest software (BD Biosciences) and
analyzed by FlowJo software (Tree Star Inc.).

RNA Isolation, cDNA Synthesis and
Quantitative PCR (qPCR)
Peripheral blood mononuclear cells (PBMCs) from
patients with gout and HC were isolated using FicollHypaque density gradient centrifugation. Total RNA in
human PBMCs and mouse BMDMs was extracted using
Trizol reagent (Invitrogen, USA) and reverse-transcribed
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Figure 1 miR-223 was required for macrophage homeostasis, but not development and phagocytosis. (A) The cells harvested from peritoneal cavity with 2 mL PBS were stained with
anti-F4/80 and anti-CD11b antibodies and analyzed by flow cytometry. (B) The bone marrow cells were cultured and induced by Dulbecco’s modified Eagle’s medium (DMEM) with 30
ng/mL macrophage colony-stimulating factor for 7 days. The DMEM was refreshed every 2 days until the cells were harvested and the purity of the bone marrow-derived macrophages
(BMDMs) were then identified with flow cytometry. The BMDMs were represented by positive F4/80 and CD11b. (C) Monosodium urate (MSU) crystal phagocytosis was analyzed by
flow cytometry in BMDMs from miR-223 KO and WT mice at different time points after MSU crystal challenge in vitro. n=3–5 for each group and unpaired t-test was used for each
group at indicated time points. The results are representative of 3 independent experiments. n=3–5 for each group. **P<0.01.
Abbreviation: NS, not significant.
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into cDNA using reverse transcription reagents
(Invitrogen, USA) according to the manufacturer’s proto
cols. Real-time qPCR was performed with Power SYBR
Green PCR Master Mix (Applied Biosystems, USA). The
gene primer sequences (Table 2) were synthesized by

Eurofins Genomics (Louisville, USA) or a biological engi
neering company (Shanghai, China). Gene expression
analysis was performed using the 2−ΔΔCT or 2−ΔCT method.
The expression of miR-223 (ABI: ID002295, miR-2233p) in PBMCs, sorted cells and BMDMs were measured

Table 2 Sequences of Human and Murine Genes Primers Used in Our Study
Gene Name

Primer Sequence

Human NLRP3

Forward
Reverse

5ʹ-CCCCGTGAGTCCCATTA-3ʹ
5ʹ-GACGCCCAGTCCAACAT-3ʹ

Human β-actin

Forward
Reverse

5ʹ-GAGCTACGAGCTGCCTGACG −3ʹ
5ʹ-GTAGTTTCGTGGATGCCACAG-3ʹ

Murine NLRP3

Forward
Reverse

5ʹ-CGTGGTTTCCTCCTTTTGTATT-3ʹ
5ʹ-CGACCTCCTCTCCTCTCTTCTT-3ʹ

Murine IL-1β

Forward
Reverse

5ʹ-GGGCCTCAAAGGAAAGAATC-3ʹ
5ʹ-CTCTGCTTGTGAGGTGCTGA-3ʹ

Murine TNF-α

Forward
Reverse

5ʹ-ACAAAGGTGCCGCTAACCACATGT-3ʹ
5ʹ-ATGCTGCTGTTTCAGTCGAAGGCA-3ʹ

Murine β-actin

Forward
Reverse

5ʹ-CAACGAGCGGTTCCGATG-3ʹ
5ʹ-GCCACAGGATTCCATACCCA-3ʹ

Murine ASC

Forward
Reverse

5ʹ-TCACAGAAGTGGACGGAGTG-3ʹ
5ʹ-TGTCTTGGCTGGTGGTCTCT-3ʹ

Murine caspase-1

Forward
Reverse

5ʹ-CGTGGAGAGAAACAAGGAGTG-3ʹ
5ʹ-AATGAAAAGTGAGCCCCTGAC-3ʹ

Murine P2X7R

Forward
Reverse

5ʹ-ATCCACTTCCCCGGCCACAA-3ʹ
5ʹ-CCTCCAGTGCCGAAAACCAGG-3ʹ

Murine TLR2

Forward
Reverse

5ʹ-CCAAAGAGCTCGTAGCATCC-3ʹ
5ʹ-AGGGGCTTCACTTCTCTGCT-3ʹ

Murine TLR4

Forward
Reverse

5ʹ-CAAGAACATAGATCTGAGCTTCAACCC-3ʹ
5ʹ-GCTGTCCAATAGGGAAGCTTTCTAGAG-3ʹ

Murine MyD88

Forward
Reverse

5ʹ-CGGAACTTTTCGATGCCTTT-3ʹ
5ʹ-TAGTTGCCGGATCATCTCCT-3ʹ

Murine STAT1

Forward
Reverse

5ʹ-TCACAGTGGTTCGAGCTTCAG-3ʹ
5ʹ-CGAGACATCATAGGCAGCGTG-3ʹ

Murine STAT3

Forward
Reverse

5ʹ-GGGCCATCCTAAGCACAAAG-3ʹ
5ʹ-GGTCTTGCCACTGATGTCCTT-3ʹ

Murine SOCS1

Forward
Reverse

5ʹ-CACCTTCTTGGTGCGCG-3ʹ
5ʹ-AAGCCATCTTCACGCTGAGC-3ʹ

Murine IL-6

Forward
Reverse

5ʹ-TCCAGTTGCCTTCTTGGGAC-3ʹ
5ʹ-GTACTCCAGAAGACCAGAGG-3ʹ

Murine MCP-1

Forward
Reverse

5ʹ-CATCCACGTGTTGGCTCA-3ʹ
5ʹ-GATCATCTTGCTGGTGAATGAGT-3ʹ

Murine CXCL5

Forward
Reverse

5ʹ-ATCACCTCCAAATTAGCGATCA-3ʹ
5ʹ-TTCTGTTGCTGTTCACGCT-3ʹ
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using TaqMan MicroRNA Assays (Applied Biosystems,
USA) according to the manufacturer’s protocols. The
TaqMan MicroRNA Assay for U6 snRNA (ABI:
ID001973) was used to normalize the relative abundance
of microRNAs.

proteins were visualized using an enhanced chemilumines
cence system (Amersham Biosciences), according to the
manufacturer’s instructions. Fold changes were assessed
using Image J software.
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Statistical Analysis
Enzyme-Linked Immunosorbent Assay
(ELISA) Analysis
IL-1β (88–7013-88), IL-6 (88–7064-88), and MCP-1
(88–7503-88) in APLF or PCLF were determined
using ELISA kits from eBioscience (USA) following
the manufacturer’s instructions. The 96-well micro
plates were read by a VICTOR X3 multilabel plate
reader.

Data were analyzed with Prism 6.0 (GraphPad software).
Data are expressed as mean±standard deviation.
Differences between experimental groups were tested
using the unpaired t-test or a one-way analysis of variance
(ANOVA). A p values < 0.05 was considered statistically
significant.

Western Blot Analysis

Results
MSU Crystals Changed miR-223
Expression in BMDMs from WT Mice

Proteins in BMDMs or PBMCs were extracted by RIPA
lysis buffer (Thermo Scientific) containing protease or
phosphatase inhibitors. The proteins (50–70 μg) were
separated by 10% SDS-PAGE and transferred to
a polyvinylidene fluoride membrane (Bio-Rad). After
blocking with 5% non-fat milk (Sigma, USA) for 1 h,
the membrane was incubated with primary antibodies
[anti-NLRP3 antibody (#15,101), anti-IL-1β antibody
(#4283), and anti-β-actin antibody (#3700) (all from Cell
Signaling Technology)] at 4°C overnight. Secondary anti
bodies conjugated to horseradish peroxidase were incu
bated for 1 h at room temperature. Immunoreactive

We firstly validated the expression of miR-223 in BMDMs
and large peritoneal macrophages (LPMs). As shown in
Figure 2A, the levels of miR-223 in BMDMs and LPMs
from miR-223 KO mice were significantly lower than
those from WT mice. In the in vitro functional experiment,
miR-223 was quickly and strongly up-regulated in
BMDMs from WT mice after MSU treatment in vitro
and then decreased rapidly to an extremely low level.
However, the baseline level was maintained in miR-223
KO mice (Figure 2B). These data indicated that miR-223
could be significantly inhibited by MSU crystals although
it was promoted at early phase.

Figure 2 miR-223 was validated both in miR-223 knock-out (KO) and wild-type (WT) mice and changed in bone marrow-derived macrophages (BMDMs) from WT mice
treated with monosodium urate (MSU) crystals in vitro. (A) Relative expression of miR-223 was measured by TaqMan-PCR in BMDMs and in large peritoneal macrophages
(LPMs) from WT and miR-223 KO mice. (B) Relative expression of miR-223 was measured by TaqMan-PCR in BMDMs from WT mice treated with MSU crystals (100 μg/
mL) for different time-points up to 24 h. Point 0 represented treatment without MSU crystals. The results are representative of 3 independent experiments. n=3–5 for each
group, and the unpaired t-test was used for each group, and the Bonferroni post-test was used for the comparison between baseline and MSU crystals. Compared to the
untreated group. **P<0.01, ***P<0.001.
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miR-223 Was Required for Macrophage
Homeostasis, but Not Development and
Phagocytosis
We examined whether miR-223 deficiency could
impair macrophage development and homeostasis
using miR-223 KO mice. In comparison with WT
mice, the percentage of macrophages was significantly
down-regulated in cells profile from the peritoneal
cavity of miR-223 KO mice (Figure 1A). The percen
tage of BMDMs in miR-223 KO mice was not sig
nificantly changed compared to WT mice (Figure 1B).
It suggested that miR-223 may be required for macro
phage homeostasis, but not macrophage development.
To further evaluate the potential role of miR-223 in
the MSU crystals phagocytosis of macrophages,
BMDMs were incubated with MSU crystals. The pha
gocytosis of macrophages from miR-223 KO mice was
comparable to that from WT mice (Figure 1C), sug
gesting that lack of miR-223 did not block the macro
phage phagocytosis.

miR-223 Deficiency Exacerbated
MSU-Induced Inflammation in the Foot
Pad and Ankle Joint Models
To further address whether miR-223 deficiency affects the
phenotype in the MSU-induced gouty inflammatory response
in vivo, foot pad and ankle joint models were applied to mimic
acute gouty arthritis in humans. Compared with WT mice,

Yang et al

significant increases in swelling indices of the foot pad were
observed in miR-223 KO mice at 6 h and peaked at 24 h, and
were still high at 48 h after administration of MSU crystals
although this almost returned to the same level seen at 6
h (Figure 3A). Consistent with the findings with the foot
pad, the ankle swelling indices in miR-223 KO mice also
markedly increased compared with those in WT mice
(Figure 3B). In addition, inflammatory cells were assayed by
immunohistochemistry of ankle joint tissue slices.
Inflammatory cell infiltration was significantly increased in
miR-223 KO mice compared with WT mice (Figure 3C).
These data collectively demonstrated that miR-223 deficiency
could prominently promote the clinical phenotype of MSUinduced inflammatory response.

miR-223 Deficiency Aggravated
MSU-Induced Inflammatory Cell
Infiltration and Cytokine Release in the
Air Pouch and Peritonitis Models
To ascertain the effects of miR-223 deficiency in MSUinduced inflammation in vivo, a murine air pouch model of
MSU crystals-induced inflammation was assessed at different
time-points. At 12 h after MSU injection, there was a marked
increase in the total cell number in subcutaneous APLF
(Figure 4A), and the total cell number in APLF in miR-223
KO mice was maintained at a high level at 24 h. Moreover, for
neutrophils (Figure 4B), as the major APLF population, both
the cell number and the ratio increased at 12 and 24 h in miR223 KO mice (Figure 4C and D). However, both the cell

Figure 3 miR-223 deficiency exacerbated acute arthritis in response to monosodium urate (MSU) crystals. (A) 1 mg/40 μL MSU suspension was injected into the right foot
pad of wild-type (WT) and miR-223 knock-out (KO) mice, and thickness of the foot pad was determined at 0, 6, 24 and 48 h after MSU administration. (B) 0.5 mg/20 μL
MSU crystals were injected into the left ankle joints, and the ankles were measured at 0, 6, 24 and 48 h after MSU administration; swelling was expressed as a ratio > 0.15
which indicated inflammation. (C) The ankle joints were harvested 12 h after MSU treatment in 4% formalin and then tissue slices were prepared and stained with
hematoxylin and eosin (H&E). Data are expressed as mean ± SEM. The results are representative of 3 independent experiments. n=6–8 for each group and the unpaired
t-test was used for each group at the indicated time points. *P<0.05, **P<0.01.
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Figure 4 miR-223 deficiency enhanced monosodium urate (MSU)-induced inflammatory cell infiltration and cytokine secretion in the air pouch model. (A) Total cell
numbers were counted using a hematocytometer. (B) Neutrophils and macrophages were gated by Fluorescence-Activated Cell Sorting (FACS). (C–F) Infiltrated
neutrophils (C, D) and macrophages (E, F) were analyzed using FlowJo software. Infiltrated macrophages were represented by F4/80+, while neutrophils were represented
by Ly6G+. (G–I) The protein levels of IL-1β (G), IL-6 (H) and MCP-1 (I) in air pouch lavage fluid harvested at 3, 6, 12 and 24 h were measured using ELISA. n=4–6 for each
group and the unpaired t-test was used for each group at the indicated time points. *P<0.05, **P<0.01.

number and the ratio of macrophages, the second major infil
trating cells, decreased at 6, 12 and 24 h (Figure 4E and F).
Furthermore, the levels of IL-1β, IL-6 and MCP-1 in APLF,
particularly at the early phase of the inflammatory response,
were markedly elevated in miR-223 KO mice compared with
WT mice (Figure 4G–I).
The peritoneal cavity model was used to analyze the
cellular phenotype of miR-223 in gout. In comparison
with WT mice, it was found that the total cell number
in PCLF in miR-223 KO mice increased at 3 and 6
h (Figure 5A). Of note, infiltrating neutrophils

1852

Powered by TCPDF (www.tcpdf.org)

https://doi.org/10.2147/JIR.S307796

DovePress

(Figure 5B) were not only increased in number but
also in ratio in miR-223 KO mice after MSU treatment
at 3 and 6 h (Figure 5C and D). However, neither the
number nor the ratio of macrophages were significantly
different (Figure 5E and F). Moreover, there was
a significant elevation of IL-1β, IL-6 and MCP-1 in
PCFL from miR-223 KO mice (Figure 5G–I). Our
results suggested that deficiency of miR-223 could
aggravate infiltration of neutrophils and production of
pro-inflammatory cytokines implicated in the process
of gouty inflammation.
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Figure 5 miR-223 deficiency aggravated neutrophil infiltration and pro-inflammatory cytokine secretion in monosodium urate (MSU)-induced peritonitis. (A) 3 mg/0.5 mL
MSU suspension was injected into the peritoneal cavity, the lavage fluid was harvested at different time points. (A) Total cell numbers were counted using
a hematocytometer. (B–F) Neutrophils and macrophages were analyzed by FACS. Macrophages were represented by F4/80+, while neutrophils were represented by
Ly6G+. (G–I) IL-1β, IL-6 and MCP-1 levels in peritoneal cavity lavage fluid at the indicated time points were detected using ELISA. The results are representative of 3
independent experiments. n=4–6 for each group and the unpaired t-test was used for each group at the indicated time points. *P<0.05, **P<0.01.

miR-223 Deficiency Enhanced the
MSU-Induced Inflammatory Response by
Directly Targeting NLRP3
To further clarify the potential molecular mechanism of miR223 in the enhancement of MSU-induced gouty inflammation,
pro-inflammatory gene expression was evaluated in BMDMs
exposed to MSU in vitro. In comparison with WT mice, TNFα mRNA level was significantly increased in miR-223 KO
BMDMs exposed to MSU crystals (Figure 6A). It was further

Journal of Inflammation Research 2021:14

confirmed that the level of TNF-α secretion was markedly
elevated in miR-223 KO BMDMs treated with MSU for 2 and
4 h (Figure 6B and C). In addition, the key genes related to the
signaling pathways in gouty inflammation were not altered in
miR-223 KO mice (Supplementary Figure 1 and 2).
The mRNA and protein levels of NLRP3, which was one
of the miR-223 potential target genes in both humans and mice,
were measured in BMDMs treated with MSU in vitro. As
expected, NLRP3 mRNA levels were not altered in miR-223
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Figure 6 miR-223 deficiency promoted the monosodium urate (MSU)-induced inflammatory response by targeting NLRP3. (A) Relative expression of TNF-α mRNA in
bone marrow-derived macrophages (BMDMs) treated with MSU (100 μg/mL) at 0, 4 or 8 hours was detected by real-time qPCR. (B and C) BMDMs from WT and miR-223
KO mice were incubated with MSU crystals (100 μg/mL) for 0, 2, 4 or 8h and brefeldin A (1:1000) was added to block cytokine secretion 1 h after MSU crystals
administration. The BMDMs were represented by F4/80+CD11b+. (B) TNF-α was detected by FACS. (C) The ratio of BMDMs producing TNF-α was compared between
miR-223 KO and WT mice. (D and E) Relative expression of NLRP3 (D) and IL-1β (E) mRNA in BMDMs treated with MSU (100 μg/mL) at 0, 4 or 8 h were detected by
real-time qPCR. (F) The protein levels of NLRP3 and IL-1β p31 in the BMDMs from miR-223 KO and WT mice treated with MSU at 0, 2, 4 or 8 h were detected by Western
blot and were analyzed using Image J software. The results are representative of 3 independent experiments. n=3–5 for each group, and the unpaired t-test was used for each
group at the indicated time points. *P<0.05, **P<0.01, ***P<0.001.

KO BMDMs treated with MSU (Figure 6D), while NLRP3
protein levels increased significantly compared with those in
WT mice (Figure 6F), although the NLRP3 protein levels were
improved both in miR-223 KO and WT BMDMs after MSU
treatment. In addition, IL-1β mRNA expression was also com
parable in miR-223 KO and WT mice (Figure 6E), whereas IL1β protein level in miR-223 KO mice increased significantly
compared with WT mice (Figure 6F). Collectively, these data
suggested that miR-223 deficiency exacerbated the acute
inflammatory response to MSU crystals by targeting NLRP3.

miR-223 Level Was Down-Regulated in
PBMCs from Gout Patients
To finally verify miR-223 level in gout patients, the miR223 level was analyzed in PBMCs from gout patients and
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healthy controls (HC). Our findings showed that miR-223
was down-regulated in gout patients compared to HC.
Furthermore, low miR-223 did not differ between acute
gout and intercritical gout (Figure 7A). A functional
in vitro study was designed to validate the effects of
altered miR-223 level in humans. Consistent with the
results observed above, miR-223 level was significantly
down-regulated in PBMCs from HC following treatment
with MSU crystals to trigger the acute inflammatory
response (Figure 7B). In addition, the levels of NLRP3
mRNA in PBMCs, and even IL-1β protein in the super
natant, increased in these cells from HC exposed to MSU
in vitro (Figure 7C and D). Thus, it suggested that gout
patients with low miR-223 level might have a distinct
genetic profile mediated by MSU crystals.
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Figure 7 miR-223 level was down-regulated in peripheral blood mononuclear cells
(PBMCs) from patients with gout. (A) miR-223 level was measured in PBMCs from
patients with acute gout (AG, n=80), intercritical gout (IG, n=40) and healthy
controls (HC, n=40). (B–D) The PBMCs from HC treated with MSU crystals
(100 μg/mL) for 12 h in vitro were harvested for measurement of miR-223 (B),
NLRP3 mRNA (C) and IL-1β protein (D) in the supernatant. The miRNA or mRNA
level was detected by real-time qPCR, and the protein level was measured using
ELISA. The results are representative of 3 independent experiments. n=3 for each
group (B–D). One-way analysis of variance or the paired t-test, and the Bonferroni
post-test were used for comparisons between the groups. **P<0.01. ***P<0.001.

Discussion
Although MSU has been identified as a causative agent in
gout for more than 100 years, its complicated mechanism
was unknown until the discovery of the NLRP3 inflamma
some a decade ago.21 Currently, the NLRP3 inflamma
some is considered a master switch that modulates gouty
inflammatory response. Emerging data have demonstrated
that miRNAs negatively regulated gene expression posttranscriptionally by binding to the 3ʹ-UTR of target
mRNAs.7,8 Previous in vitro studies reported that miR223 played a crucial role in modulation of MSU-induced
inflammatory response due to negative regulation of
NLRP3 inflammasome activity.11,22 However, there is
still a lack of direct evidence to further support that miR223 is indeed involved in the MSU-induced inflammation.
To better understand the biological function of miR223 involved in gouty inflammation in vitro and in vivo,
we confirmed that miR-223 expression was up-regulated
in the early phase and then decreased in BMDMs from
WT mice after MSU treatment in vitro, but this did not
occur in miR-223 KO mice. These results indicated that
miR-223 expression was promoted in the early phase of
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MSU-induced acute gouty inflammation and was sup
pressed following constant challenge with MSU crystals.
However, the exact mechanisms of those change still
remained unclear. It could be attribute to the timeliness
of miR-223 expression and the several fine-regulatory
mechanisms such as regulation of transcript factor,23
circRNA sponge24 and macrophage polarization.10
MiR-223 is involved in determining the identity of cell
types in the myeloid compartment, especially the neutro
phils and macrophages.10 A previous study25 showed that
murine peritoneal cavity harbors a number of immune
cells, which is approximately composed of 30% in macro
phages, 50% in B cells and 10% in T cells. It has been
shown that lack of miR-223 could affect proliferation and
differentiation of neutrophils.15 Macrophage, as one of the
myeloid cells, plays a critical role in recognition and
phagocytosis of MSU crystals and then triggers NLRP3
inflammasome activation, leading to IL-1β release.26–28 To
assess if miR-223 affected macrophages development and
homeostasis in miR-223 KO mice, we analyzed the macro
phages from peritoneal cavity and BMDMs as well. In
comparison with WT mice, the percentage of macrophages
from miR-223 KO mice was significantly down-regulated,
whereas the percentage of BMDMs was similar. Besides,
the phagocytosis of macrophages was comparable between
miR-223 KO mice and WT mice. Collectively, those data
suggested that miR-223 was required for macrophage
homeostasis, but not development and phagocytosis.
It is well known that acute arthritis is a clinical man
ifestation of gout and includes the following clinical
features:29 Severe pain, redness, warmth, swelling, and
disability. Firstly, we evaluated the clinical phenotype of
the foot pad and ankle joint models in miR-223 KO mice
in vivo which mimic acute gouty arthritis in humans. Our
findings showed that a significant inflammatory response
induced by MSU was observed in the foot pad and ankle
models in miR-223 KO mice. Neutrophils and macro
phages were the major cell populations implicated in the
inflammatory response in gout.27,30,31 When the inflamma
tory response was triggered by MSU at a local site, proinflammatory cytokines and chemokines were quickly
released to recruit more neutrophil and macrophage/mono
cyte infiltration at the inflammatory site. According to the
literature,32 pro-inflammatory cytokines, such as IL-1β,
IL-6 and TNF-α, were elevated within 2 h and peak at 4
h. The air pouch and peritoneal cavity models32,33 were
used to identify the cellular phenotype in miR-223 defi
cient mice. Our analyses revealed that deletion of miR-223
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recruited more infiltrating neutrophils to the inflammatory
site and produced more cytokines. These data verified that
miR-223 deficiency could obviously give rise to enhance
ment of gouty inflammation in vivo.
The modulatory mechanisms of gout were determined
to understand and regulate gouty flares. At the early stage
of MSU crystals-triggered inflammatory response, proinflammatory mediators from macrophages were activated
and released, and then participated in the acute attack
process.32,33 It was reported in a previous in vitro study
that miR-223 can attenuate IL-1β secretion through inhibi
tion of NLRP3 inflammasome activity,11 suggesting that
miR-223 could be a modulator of NLRP3 inflammasome
signaling pathway involved in the pathogenesis of gouty
inflammation. In our in vitro study, TNF-α mRNA and
protein levels from miR-223 KO BMDMs increased mark
edly compared with WT mice. However, there were no
alterations in crucial genes related to the pro-inflammatory
cytokines involved in the two signaling pathways of gouty
inflammation. Based on the miRBase database and pre
vious studies,11,22 NLRP3, which is one of the potential
target genes of miR-223 by binding to the 3ʹ-UTR in both

humans and mice, was validated.12,13 We found that
NLRP3 protein increased in miR-223 KO compared with
WT BMDMs treated with MSU, while NLRP3 mRNA
showed comparable changes. Consistent with the two
emerging studies that the miR-223 was involved in the
regulation of gouty inflammation via targeting NLRP3
in vitro functional experiment,12,13 our findings demon
strated that deletion of miR-223 exacerbated MSUinduced inflammatory response by targeting NLRP3, and
alleviating the specific inhibition of NLRP3 inflammasome
activity.
In patients with gout, low miR-223 level was observed
in PBMCs from those with both acute gout and intercri
tical gout. Consistent with the observation that miR-223
deficiency was associated with an increase in the MSUinduced inflammation, a reduced miR-223 level in PBMCs
from HC was observed following treatment with MSU
crystals in vitro, in parallel with increased NLRP3 and
IL-1β.
There are some limitations associated with the current
study. Firstly, in addition to miR-223 KO mice, we should
have determined the phenotype of miR-223 knock-in mice

Figure 8 The schematic diagram shows that miR-223 deficiency exacerbates acute inflammatory response to monosodium urate crystals by targeting NLRP3.
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in vivo. Secondly, based on validated targets of miR-223
in literature review described,10 whether miR-223 target
ing critical candidate genes in the gouty inflammatory
response could target other different genes, such as
TLR4,34 should have been explored. Thirdly, more
research is necessary to determine the role of miR-223 in
the regulatory mechanism of gouty inflammation in gout
patients considering that the entire human body is com
posed of many complicated and sophisticated organs and
is also modulated under the accurate surveillance of
immune cells.

Conclusion
In this study, we revealed that miR-223 was downregulated in gout patients and miR-223 deficiency exacer
bated inflammatory response in diverse murine models.
These findings from humans and mice indicate that miR223 deficiency exacerbated the acute inflammatory
response to MSU crystals by targeting NLRP3 (Figure
8). Therefore, up-regulation of miR-223 may serve as
a potential therapeutic strategy for MSU crystal-induced
acute gouty inflammation.
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